Showing results (1-10 of 134) with videos related to
Sort By:
Pageof 14
British Journal of Clinical Pharmacology|June 17, 2017
The long and winding road for selective androgen receptor modulatorsJames T DaltonMolecular Interventions|March 7, 2007
Ockham's razor and selective androgen receptor modulators (SARMs): are we overlooking the role of 5alpha-reductase?Wenqing Gao, James T DaltonCancers|December 6, 2016
Androgen Receptor: A Complex Therapeutic Target for Breast CancerRamesh Narayanan, James T DaltonDrug Discovery Today|March 3, 2007
Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs)Wenqing Gao, James T DaltonExpert Opinion on Investigational Drugs|March 22, 2006
Therapeutic potential of the SARMs: revisiting the androgen receptor for drug discoveryScott Segal, Ramesh Narayanan, James T DaltonMolecular Interventions|July 5, 2005
Discovery and therapeutic promise of selective androgen receptor modulatorsJiyun Chen, Juhyun Kim, James T DaltonPharmaceutical Research|July 15, 2006
Pharmacokinetics and pharmacodynamics of nonsteroidal androgen receptor ligandsWenqing Gao, Juhyun Kim, James T DaltonInvestigational New Drugs|April 24, 2016
Pharmacokinetic drug interactions of the selective androgen receptor modulator GTx-024(Enobosarm) with itraconazole, rifampin, probenecid, celecoxib and rosuvastatinChristopher C Coss, Amanda Jones, James T DaltonMolecular and Cellular Endocrinology|June 19, 2017
Development of selective androgen receptor modulators (SARMs)Ramesh Narayanan, Christopher C Coss, James T DaltonArchives of Pharmacal Research|October 10, 2013
Effect of para halogen modification of S-3-(phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethyl-phenyl)-propionamides on metabolism and clearanceJuhyun Kim, Christopher C Coss, James T DaltonPageof 14